Recent Developments in Parkinson's and Lung Cancer Therapies
Biogen and Denali's experimental treatment for Parkinson's disease has not achieved its trial objectives, while Merck's lung cancer therapy appears to offer potential benefits.
Editorial Staff 28 days ago